Roche Diagnostics Gmbh

Boehringer Mannheim Gmbh

Genentech, Inc.

F. Hoffmann-la Roche Ag

Michael Wiedmann

Christoph Seidel

Ursula-Henrike Wienhues

Urban Schmitt

Barbara Upmeier

Manfred Motz

Elke Faatz

Erasmus Huber

Roberto Falkenstein

Thomas Meier

Erwin Soutschek

Frederic Donie

Volker Klemt

Rosemarie Kientsch-Engel

Dittmar Schlieper

Eva Höss

Bernhard Spensberger

Wolfgang Koehnlein

Klaus Schwendner

Eva H&ouml;ss

Beatus Ofenloch-H&auml;hnle

Cornelia Kruse-Müller

Tobias Graf

Cornelia Kruse-M&uuml;ller

Beatus Ofenloch-Hähnle

Michael Leiss

Franziska Edelmann

Lars Hillringhaus

Frank Zettl

Annika Kleinjans

Carina Kopp

Sanjay Gupta

Tarik Khan

Richard St John

Paul Mcdonald

Benjamin Tran

Ryan Erickson

The invention concerns a method for the immunological determination of a specific antibody in a sample liquid in which the sample liquid is incubated in the presence of a solid phase with two antigens directed against the antibody to be determined of which the first antigen carries at least one marker group and the second antigen is (a) bound to the solid phase or (b) is present in a form capable of binding to the solid phase and the antibody to be determined is detected by determining the marker group in the solid phase or/and in the liquid phase characterized in that at least one of the two antigens contains several epitope regions which react with the antibody to be determined.

Determination of a specific immunoglobulin using multiple antigens

The present invention concerns a polypeptide which is composed of the amino acids 1207&#xb1;10 to 1488&#xb1;10 of a hepatitis C virus and of less than 20 foreign amino acids and the use of this polypeptide as an antigen in an immunological test.

Method for determining early HCV seroconversion

The present invention concerns a polypeptide which is composed of the amino acids 1207&plusmn;10 to 1488&plusmn;10 of a hepatitis C virus and of less than 20 foreign amino acids and the use of this polypeptide as an antigen in an immunological test.

Recombinant antigen from the NS3 region of the hepatitis C virus

The present invention concerns a polypeptide which is composed of the amino acids 1207.+-.10 to 1488.+-.10 of a hepatitis C virus and of less than 20 foreign amino acids and the use of this polypeptide as an antigen in an immunological test.

The invention addresses new photo-activatable biotin derivatives having the formula I ##STR1## wherein R=�(CH.sub.2).sub.n --O.sub.m !.sub.q --�(CH.sub.2).sub.r --O.sub.s !.sub.t --(CH.sub.2).sub.p

Photo-activatable biotin derivatives and their use to reduce

Interference eliminating agent for application in immunoassays

Elimination of rheumatoid factor interference using anti-FD antibodies

Growing community of inventors

Penzberg, Germany

Michael Wiedmann